DK0486536T3 - Antivirale midler midler indeholdende sulfoquinovosylglycerolderivater og analoger deraf - Google Patents

Antivirale midler midler indeholdende sulfoquinovosylglycerolderivater og analoger deraf

Info

Publication number
DK0486536T3
DK0486536T3 DK90911686.5T DK90911686T DK0486536T3 DK 0486536 T3 DK0486536 T3 DK 0486536T3 DK 90911686 T DK90911686 T DK 90911686T DK 0486536 T3 DK0486536 T3 DK 0486536T3
Authority
DK
Denmark
Prior art keywords
hiv
sulfoquinovosylglycerol
analogs
derivatives
antiviral agents
Prior art date
Application number
DK90911686.5T
Other languages
English (en)
Inventor
Michael R Boyd
John H Ii Cardellina
Kenneth M Snader
Kirk R Gustafon
Gregory M L Patterson
James B Mcmahon
Owen S Weislow
Robert H Shoemaker
Kenneth D Paull
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of DK0486536T3 publication Critical patent/DK0486536T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/06—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical being a hydroxyalkyl group esterified by a fatty acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK90911686.5T 1989-08-15 1990-08-03 Antivirale midler midler indeholdende sulfoquinovosylglycerolderivater og analoger deraf DK0486536T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39378089A 1989-08-15 1989-08-15

Publications (1)

Publication Number Publication Date
DK0486536T3 true DK0486536T3 (da) 1995-04-10

Family

ID=23556218

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90911686.5T DK0486536T3 (da) 1989-08-15 1990-08-03 Antivirale midler midler indeholdende sulfoquinovosylglycerolderivater og analoger deraf

Country Status (9)

Country Link
EP (1) EP0486536B1 (da)
JP (1) JPH0747540B2 (da)
AT (1) ATE113210T1 (da)
AU (1) AU635057B2 (da)
CA (1) CA2064772A1 (da)
DE (1) DE69013688T2 (da)
DK (1) DK0486536T3 (da)
ES (1) ES2064748T3 (da)
WO (1) WO1991002521A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2774094B1 (fr) * 1998-01-26 2001-04-13 Ifremer Procede de purification de sulfoquinovosyldiacylglycerol par chromatographie de partage centrifuge
JP3851461B2 (ja) 1998-09-04 2006-11-29 東洋水産株式会社 ピラノシドおよびその製造方法
EP1164140B1 (en) * 1999-02-26 2003-07-09 Toyo Suisan Kaisha, Ltd. Novel sulfofucosylacylglycerol derivatives and utilization thereof as drugs
CN1151795C (zh) * 1999-02-26 2004-06-02 东洋水产株式会社 含(磺基吡喃糖基)酰基甘油衍生物的药品
DE60003794T2 (de) 1999-02-26 2004-06-17 Toyo Suisan Kaisha, Ltd. Sulforhamnosylacylglycerin-derivate und ihre verwendung als medikamente
US6518410B2 (en) 1999-02-26 2003-02-11 Toyo Suisan Kaisha, Ltd. Sulfoquinovosylacylglycerol derivative, and use thereof as medicaments
WO2003006028A1 (en) 2001-07-09 2003-01-23 Toyo Suisan Kaisha, Ltd. Novel immunosuppressants
FR2840318B1 (fr) * 2002-05-29 2004-12-03 Quoc Kiet Pham Nouveaux sulfolipides antiretroviraux extraits de spirulines, leur procede d'obtention, les compositions les contenant et leur utilisation comme inhibiteurs de la transcriptase inverse des virus vih
FR2867475B1 (fr) * 2004-06-10 2006-09-22 Quoc Kiet Pham Nouveaux sulfolipides antiretroviraux extraits de spirulines, leur procede d'obtention, les compositions les contenant et leur utilisation comme inhibiteurs de la transcriptase inverse des virus vih
EP2130834A4 (en) 2007-07-20 2012-09-05 Toyo Suisan Kaisha NOVEL SULPHONATED SUGAR DERIVATIVES AND ITS USE IN MEDICINAL ACTIVE SUBSTANCES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0338092A1 (en) * 1987-10-30 1989-10-25 Chugai Seiyaku Kabushiki Kaisha Anti-hiv agent

Also Published As

Publication number Publication date
EP0486536A1 (en) 1992-05-27
DE69013688D1 (de) 1994-12-01
CA2064772A1 (en) 1991-02-16
EP0486536A4 (en) 1992-09-16
AU635057B2 (en) 1993-03-11
ATE113210T1 (de) 1994-11-15
AU6067990A (en) 1991-04-03
WO1991002521A1 (en) 1991-03-07
DE69013688T2 (de) 1995-05-18
JPH05501105A (ja) 1993-03-04
EP0486536B1 (en) 1994-10-26
ES2064748T3 (es) 1995-02-01
JPH0747540B2 (ja) 1995-05-24

Similar Documents

Publication Publication Date Title
DK166277C (da) Anvendelse af pyridazinaminer til fremstilling af antivirale praeparater, pyridazinaminer til brug som antivirale midler, antivirale praeparater, pyridazinaminer og fremgangsmaade til fremstilling deraf
FI20001231A7 (fi) 2-Deoksi-2,3-didehydro-N-asetyylineuramiinihapon johdannaisia ja niiden analogeja ja niiden käyttö antiviraalisina aineina
DK224286A (da) 2',3'-dideoxy-nucleosider
FI832355A0 (fi) 9-(2-hydroxyetoximetyl)guanidin-derivat
DK602988D0 (da) Nukleosidderivater med antiviral virkning og laegemiddelpraeparat indeholdende saadanne forbindelser
DK0486536T3 (da) Antivirale midler midler indeholdende sulfoquinovosylglycerolderivater og analoger deraf
DK0777669T3 (da) 4-[2-amino-6-(cyclopropylamino)-9H-purin-yl]-2-cyclopenten-1-methanolsuccinat som antiviralt middel
DK326586D0 (da) Antivirale pyrimidinforbindelser, farmaceutiske kompositioner indeholdende forbindelserne og kompositionernes fremstilling
ATE71840T1 (de) Virushemmende nukleosidmischung.
MC1930A1 (fr) Produit antiviral
SE8203856D0 (sv) Novel derivatives of guanine ii
US5596018A (en) Antiviral agents against aids-causing virus
DE68914809D1 (de) Antivirale Wirkstoffe.
DK0516660T3 (da) Anvendelse af S-adenosylmethionin som middel mod virale infektioner med retrovira
ES8308335A1 (es) Un procedimiento para la preparacion de nuevos derivados de desoxiuridina.
DK410189D0 (da) Farmaceutisk praeparat til inhibering af infektion med vira, som fremkalder aids
ES2078380T3 (es) Oligofosfatos de accion antiviral.
Vogt et al. Effect of daily zidovudine (AZT) pulse-therapy on replication of human immunodeficiency virus type 1 and type 2 in vitro
TH13381A (th) องค์ประกอบเภสัชกรรมสำหรับการยับยั้งการติดเชื้อไวรัสเอดส์
TH10132A (th) การยับยั้งไวรัสที่ทำให้เกิดภูมิคุ้มกันบกพร่องในคน (hiv) โดยการทำงานร่วมกันแบบเสริมของอนุพันธุ์นิวคลีโอไซด์